Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis
Clinical trial NCT03897075 · COMPLETED
Trial details
- NCT number
- NCT03897075
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-13
- Primary completion
- 2024-04-05
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.